Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fcvm.2021.691609 http://scihub22266oqcxt.onion/10.3389/fcvm.2021.691609 34355029!8329030!34355029     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34355029&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Front+Cardiovasc+Med 2021 ; 8 (?): 691609 Nephropedia Template TP {{tp|p=34355029|t=2021. Pulmonary Rehabilitation Accelerates the Recovery of Pulmonary Function in Patients With COVID-19 |pdf=|usr=}}{{34355029}} gab.com Text Pulmonary Rehabilitation Accelerates the Recovery of Pulmonary Function in Patients With COVID-19 JO: Front Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=34355029 #FOAvip Objectives: To evaluate the effect of in-hospital pulmonary rehabilitation (PR) on short-term pulmonary functional recovery in patients with COVID-19. Methods: Patients with COVID-19 (n = 123) were divided into two groups (PR group or Control group) according to recipient of pulmonary rehabilitation. Six-min walk distance (6MW), heart rate (HR), forced vital capacity (FVC), forced expiratory volume in 1 s (FEV(1)), diffusing capacity of the lung for carbon monoxide (DL(CO)), and CT scanning were measured at the time of discharge, 1, 4, 12, and 24 weeks. Results: At week one, both PR group and Control group showed no significant changes in pulmonary function. At 4 and 12 weeks, 6MW, HR, FVC, FEV(1), and DL(CO) improved significantly in both groups. However, the improvement in the PR group was greater than the Control group. Pulmonary function in the PR group returned to normal at 4 weeks [FVC (% predicted, PR vs. Control): 86.27 +/- 9.14 vs. 78.87 +/- 7.55; FEV1 (% predicted, PR vs. Control) 88.76 +/- 6.22 vs. 78.96 +/- 6.91; DLCO (% predicted, PR vs. Control): 87.27 +/- 6.20 vs. 77.78 +/- 5.85] compared to 12 weeks in the control group [FVC (% predicted, PR vs. Control): 90.61 +/- 6.05 vs. 89.96 +/- 4.05; FEV1 (% predicted, PR vs. Control) 94.06 +/- 0.43 vs. 93.85 +/- 5.61; DLCO (% predicted, PR vs. Control): 91.99 +/- 8.73 vs. 88.57 +/- 5.37]. Residual lesions on CT disappeared at week 4 in 49 patients in PR group and in 28 patients in control group (p = 0.0004). Conclusion: Pulmonary rehabilitation could accelerate the recovery of pulmonary function in patients with COVID-19. Twit Text FOAVip Pulmonary Rehabilitation Accelerates the Recovery of Pulmonary Function in Patients With COVID-19 ????Front Cardiovasc Med http://www.kidney.de/pget.php?&tw=1&pmid=34355029 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34355029 #FOAvip English Wikipedia <ref>{{Cite pmid|34355029}}</ref> Pulmonary Rehabilitation Accelerates the Recovery of Pulmonary Function in Patients With COVID-19 #MMPMID34355029 Zhu P; Wang Z; Guo X; Feng Z; Chen C; Zheng A; Gu H; Cai Y Front Cardiovasc Med 2021[]; 8 (?): 691609 PMID34355029show ga Objectives: To evaluate the effect of in-hospital pulmonary rehabilitation (PR) on short-term pulmonary functional recovery in patients with COVID-19. Methods: Patients with COVID-19 (n = 123) were divided into two groups (PR group or Control group) according to recipient of pulmonary rehabilitation. Six-min walk distance (6MW), heart rate (HR), forced vital capacity (FVC), forced expiratory volume in 1 s (FEV(1)), diffusing capacity of the lung for carbon monoxide (DL(CO)), and CT scanning were measured at the time of discharge, 1, 4, 12, and 24 weeks. Results: At week one, both PR group and Control group showed no significant changes in pulmonary function. At 4 and 12 weeks, 6MW, HR, FVC, FEV(1), and DL(CO) improved significantly in both groups. However, the improvement in the PR group was greater than the Control group. Pulmonary function in the PR group returned to normal at 4 weeks [FVC (% predicted, PR vs. Control): 86.27 +/- 9.14 vs. 78.87 +/- 7.55; FEV1 (% predicted, PR vs. Control) 88.76 +/- 6.22 vs. 78.96 +/- 6.91; DLCO (% predicted, PR vs. Control): 87.27 +/- 6.20 vs. 77.78 +/- 5.85] compared to 12 weeks in the control group [FVC (% predicted, PR vs. Control): 90.61 +/- 6.05 vs. 89.96 +/- 4.05; FEV1 (% predicted, PR vs. Control) 94.06 +/- 0.43 vs. 93.85 +/- 5.61; DLCO (% predicted, PR vs. Control): 91.99 +/- 8.73 vs. 88.57 +/- 5.37]. Residual lesions on CT disappeared at week 4 in 49 patients in PR group and in 28 patients in control group (p = 0.0004). Conclusion: Pulmonary rehabilitation could accelerate the recovery of pulmonary function in patients with COVID-19. ?Pulmonary Rehabilitation Accelerates the Recovery of Pulmonary Functio(epmc).pdf DeepDyve Pubget Overpricing